The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amended beneficial ownership statement with the SEC on November 9, 2026, reporting zero beneficial ownership of ordinary shares of TNL Mediagene as of September 30, 2026.

Key Highlights

  • Zero aggregate ownership: Both reporting persons disclosed 0.00 shares beneficially owned and 0.0% of the class of TNL Mediagene ordinary shares.
  • Event date: The filing is triggered by a qualifying event dated September 30, 2026.
  • Security covered: Ordinary Shares of TNL Mediagene, par value $0.002 per share, CUSIP G8924F121.
  • Joint filers: The Goldman Sachs Group, Inc. (incorporated in Delaware) and Goldman Sachs & Co. LLC (organized in New York) filed jointly as Amendment No. 1.
  • Signing authority: Ameen Soetan signed as attorney-in-fact for both entities on November 9, 2026.
  • Ownership threshold: The filing falls under the "Ownership of 5 percent or less of a class" provision, as stated in Item 5 of the filing.

Goldman Sachs Entities Disclose Full Exit from TNL Mediagene Ordinary Shares

According to the filing, The Goldman Sachs Group, Inc. reported sole voting power, shared voting power, sole dispositive power, and shared dispositive power each at 0.00 shares, with an aggregate beneficial ownership of 0.00 shares representing 0.0% of TNL Mediagene's ordinary share class. The same figures apply identically to Goldman Sachs & Co. LLC, which is identified in the filing as a broker-dealer registered under Section 15 of the Securities Exchange Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. Goldman Sachs & Co. LLC is described as a subsidiary of The Goldman Sachs Group, Inc.

TNL Mediagene, the issuer of the covered securities, is a media and digital content company headquartered at 23-2 Maruyamacho, Shibuya-ku, Tokyo. Its ordinary shares carry a par value of $0.002 per share. The filing notes, per Exhibit 99.3, that the reported positions reflect only certain operating units collectively described as the "Goldman Sachs Reporting Units," and that the filing "does not reflect securities, if any, beneficially owned by any operating units of GSG whose ownership of securities is disaggregated from that of the Goldman Sachs Reporting Units." The Goldman Sachs Reporting Units also disclaim beneficial ownership of securities held in certain client accounts and investment entities, as described in that exhibit.

The two entities filed jointly under a Joint Filing Agreement attached as Exhibit 99.1, in accordance with Rule 13d-1(k)(1). The filing is classified as Amendment No. 1 to a prior Schedule 13G. Both filers certify, as required, that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of TNL Mediagene.

What Was Disclosed

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC jointly amended their beneficial ownership statement for TNL Mediagene ordinary shares (CUSIP G8924F121), reporting zero shares held and 0.0% of the class as of September 30, 2026, filed November 9, 2026.